Table 3.
Human Papillomavirus Vaccination and Exposure Stratified by Residential Neighborhood-Level Poverty and HIV Prevalence
| Neighborhood poverty | Neighborhood HIV prevalence | |||
|---|---|---|---|---|
| Low poverty | High poverty | Low prevalence | High prevalence | |
| % (n) | % (n) | % (n) | % (n) | |
| Vaccination status | ||||
| Unvaccinated | 44.8 (104) | 44.9 (66) | 50.0 (40) | 38.4 (48) |
| Partially vaccinated | 23.3 (54) | 26.5 (39) | 20.0 (16) | 26.4 (33) |
| Fully vaccinated | 20.7 (48) | 16.3 (24) | 20.0 (16) | 20.0 (25) |
| Unsure | 11.2 (26) | 12.2 (28) | 10.0 (8) | 15.2 (19) |
| Anal HPV infection* | 56.0 (126) | 68.5 (100) | 54.7 (41) | 60.3 (76) |
| Oral HPV infection | 8.9 (21) | 8.5 (13) | 7.5 (6) | 6.1 (14) |
| Vaccine-preventable HPV infectiona | 30.7 (69) | 39.0 (57) | 33.3 (25) | 34.9 (44) |
| Any HPV infection† | 57.7 (131) | 71.2 (104) | 54.7 (41) | 61.4 (78) |
No significant associations between HPV type and HIV prevalence.
*
p < 0.05.
†
p < 0.01.
a
Nonavalent vaccine (HPV 6, 11, 16, 18, 31, 33, 45, 52, and 58).